bioAffinity Technologies

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$1,592
$1,446
$1,269
$1,853
Gross Profit
301
390
252
485
EBITDA
-3,013
-4,929
-3,908
-2,481
EBIT
-3,136
-5,042
-4,021
-2,636
Net Income
-3,137
-5,051
-4,060
-2,660
Net Change In Cash
1,592
1,446
1,269
1,853
Free Cash Flow
-2,498
-2,476
-2,660
-1,692
Cash
6,449
7,669
802
444
Basic Shares
1,721
1,066
800
541

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$6,161
$9,362
$2,532
$4
Gross Profit
1,430
3,379
791
4
EBITDA
-10,067
-8,330
-7,629
-5,608
EBIT
-10,572
-8,935
-7,878
-5,619
Net Income
-14,909
-9,040
-7,937
-8,154
Net Change In Cash
6,161
9,362
2,532
4
Free Cash Flow
-9,389
-7,343
-6,060
-4,290
Cash
6,449
1,105
2,821
11,413
Basic Shares
1,721
404
291
149

Earnings Calls

QuarterEPS
2025-12-31
-$0.69
2025-09-30
-$4.74
2025-06-30
-$0.17
2025-03-31
-$0.19